Profil
Alan F.
Eisenberg is currently a Venture Partner at Samsara BioCapital LLC since 2024.
Formerly, Mr. Eisenberg was VP-Global Public Policy & Government Relations at Alnylam Pharmaceuticals, Inc. from 2017 to 2023, Executive Vice President-Business Development at Biotechnology Innovation Organization from 2011 to 2012, and Finance Manager at Ford Motor Co. Mr. Eisenberg completed undergraduate studies at Union College (New York) in 1991, graduate studies at Harvard Kennedy School of Government in 1994, and graduate studies at The GW School of Business in 2003.
Postes actifs de Alan Eisenberg
| Sociétés | Poste | Début |
|---|---|---|
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01/03/2024 |
Anciens postes connus de Alan Eisenberg
| Sociétés | Poste | Fin |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/04/2023 |
| FORD MOTOR COMPANY | Directeur Financier/CFO | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Formation de Alan Eisenberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Ford Motor Co.
Ford Motor Co. Motor VehiclesConsumer Durables Manufactures and sells electric vehicles, trucks, service parts & accessories | Consumer Durables |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Union College (New York)
Union College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Kennedy School of Government
Harvard Kennedy School of Government Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW School of Business
The GW School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
















